But there is no scientific basis or genetic rationale for love.
But there is no scientific basis or genetic rationale for love," he said.
The authors employed sequencing and genotyping, pharmacogenomics, transgenic mouse models, rigorous statistical analysis, and robust human study protocols to describe and ultimately confirm the genetic rationale for the confusing efficacy of beta-blockers in African Americans.
Taken together with findings in other autoimmune diseases [ 11], there is genetic and immunological rationale for the initiation of clinical trials to investigate the safety and efficacy of anti-IL-21 therapy in RA patients (www.clinicaltrials.gov - NCT01565408 and NCT01647451) and in other diseases, including type 1 diabetes.
This chapter will discuss the rationale for genetic homogeneity and monitoring, the history of genetic monitoring from its inception to today, and current and historical means by which this may be accomplished.
The key differences in the percentage of patients with early relapse defined by genetic markers provide a rationale for building the models to predict the poor outcome, featuring genetic markers as covariates.
The rationale for genetic monitoring as a valuable management tool is that genetically based metrics provide scientifically robust insights into processes that affect standing levels of genetic diversity, offer defined benchmarks for assessing risks to a species persistence in the short- and long term, and, in principle, are linked explicitly to demographic changes in the population.
The advisory group endorsed only alterations designed to prevent babies from acquiring genes known to cause "serious diseases and disability," and only when there is no "reasonable alternative". The report provides an explicit rationale for genetic research that the federal government has avoided supporting until now, although the work is being pursued in countries like Sweden and China.
Within the limitations of a preclinical study, our data provide another rationale for genetic testing and clinical alertness in LQT patients to identify those with sodium channel mutations, in order to start or maintain sodium channel blocker therapy.
Although the cancer stem cell paradigm explains tumor heterogeneity, provides rationale for how genetic mutations might be accumulated over long time periods and suggests resistance to chemotherapeutics/radiation may be inherent and not acquired properties of specific tumor cell subpopulations in epithelial tumors [1], [2], a few key tenets of this theory have not been supported experimentally.
There is biological rationale for conducting genetic research in African populations.
